Participants 119 152 4
patients with chronic hepatitis C
Participants 484 589 4
1,046 patients enrolled in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial
Participants 591 704 4
All patients had failed prior treatment with IFN or peginterferon +/- RBV and had Ishak fibrosis scores > or = 3.
Participants 705 781 3
Four groups of patients with increasingly severe liver disease were compared
